theMednetRegister
  • Community
    • Overview
    • Experts
    • Editors
    • Fellows
    • Code of conduct
    • AI Guidelines for Physicians
  • Company
    • About Us
    • FAQs
    • Privacy Policy
    • Terms of Use
    • Careers
    • Programs
  • News
    • News Releases
    • Press Coverage
    • Publications
    • Blog
  • Contact Us
  • Sign in

Infectious Disease

Biologics   

Questions discussed in this category


Which medications have the lowest risk of tuberculosis reactivation in patients with uncertain tuberculosis history and active rheumatologic disease?
2 Answers available

Do you hold tocilizumab for patients who are diagnosed with Covid and are with mild to moderate symptoms or non-hospitalized?
1 Answer available

How does a history of splenectomy alter how you counsel patients on the infection risk of TNF inhibitors or other biologics?
1 Answer available

Are you recommending the mRNA COVID-19 vaccines to your patients with immune mediated inflammatory diseases?
5 Answers available

What is your approach to dental prophylaxis for patients on biologics?
1 Answer available
1178011747884587398061


Papers discussed in this category


Arthritis care & research, 2012-05
2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis.

N Engl J Med,
Clinical practice. Care of the asplenic patient.

Mediterr J Rheumatol, 2020 Jun 11
Infections in Patients with Rheumatoid Arthritis in the Era of Targeted Synthetic Therapies.

Related Topics in Infectious Disease

  • Breast Cancer
  • Hematologic Malignancies
  • Radiation Oncology
  • Gynecologic Oncology
  • Gastrointestinal Cancers
  • Pediatric Hematology/Oncology
  • Sarcoma
  • Thoracic Malignancies
  • Bladder Cancer
  • Medical Oncology

Copyright © 2025 theMednet
All Rights Reserved.